New Trial Tests Oral Drug Plus Nanoliposomal Irinotecan for Hard-to-Treat Bile Duct Cancer
A German phase II trial called TRITICC-2 is testing whether oral trifluridine/tipiracil combined with nanoliposomal irinotecan can improve outcomes for ...
A German phase II trial called TRITICC-2 is testing whether oral trifluridine/tipiracil combined with nanoliposomal irinotecan can improve outcomes for ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.